Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers
- 10 May 2013
- Vol. 31 (30), 3051-3058
- https://doi.org/10.1016/j.vaccine.2013.04.063
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteersVaccine, 2011
- Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.2010
- A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adultsVaccine, 2009
- Effects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 MonthsA Randomized TrialJAMA, 2008
- CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in HumansClinical Cancer Research, 2008
- Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum MalariaPLOS ONE, 2008
- Activation of Innate Immunity in Healthy Macaca mulatta Macaques by a Single Subcutaneous Dose of GMP CpG 7909: Safety Data and Interferon-Inducible Protein-10 Kinetics for Humans and MacaquesClinical and Vaccine Immunology, 2008
- Induction of Systemic TH1-Like Innate Immunity in Normal Volunteers Following Subcutaneous but Not Intravenous Administration of CPG 7909, a Synthetic B-Class CpG Oligodeoxynucleotide TLR9 AgonistJournal of Immunotherapy, 2004
- Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccineVaccine, 2004
- Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccinesVaccine, 1999